Luteolin alleviated neutrophilic asthma by inhibiting IL-36γ secretion-mediated MAPK pathways

References

• Ahsan F, Moura-Alves P, Guhlich-Bornhof U, Klemm M, Kaufmann SH, Maertzdorf J. 2016. Role of interleukin 36γ in host defense against tuberculosis. J Infect Dis. 214(3):464–474.
   PubMed Web of Science ®Google Scholar
• Aziz N, Kim MY, Cho JY. 2018. Anti-inflammatory effects of luteolin: a review of in vitro, in vivo, and in silico studies. J Ethnopharmacol. 225:342–358.
   PubMed Web of Science ®Google Scholar
• Bassoy EY, Towne JE, Gabay C. 2018. Regulation and function of interleukin-36 cytokines. Immunol Rev. 281(1):169–178.
   PubMed Web of Science ®Google Scholar
• Chen CY, Peng WH, Wu LC, Wu CC, Hsu SL. 2010. Luteolin ameliorates experimental lung fibrosis both in vivo and in vitro: implications for therapy of lung fibrosis. J Agric Food Chem. 58(22):11653–11661.
   PubMed Web of Science ®Google Scholar
• Chung KF. 2016. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies. J Intern Med. 279(2):192–204.
   PubMed Web of Science ®Google Scholar
• Chustz RT, Nagarkar DR, Poposki JA, Favoreto S Jr, Avila PC, Schleimer RP, Kato A. 2011. Regulation and function of the IL-1 family cytokine IL-1F9 in human bronchial epithelial cells. Am J Respir Cell Mol Biol. 45(1):145–153.
   PubMed Web of Science ®Google Scholar
• Das M, Ram A, Ghosh B. 2003. Luteolin alleviates bronchoconstriction and airway hyperreactivity in ovalbumin sensitized mice. Inflamm Res. 52(3):101–106.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick AM, Chipps BE, Holguin F, Woodruff PG. 2020. T2-"low" asthma: overview and management strategies. J Allergy Clin Immunol Pract. 8(2):452–463.
   PubMed Web of Science ®Google Scholar
• Fu JJ, McDonald VM, Baines KJ, Gibson PG. 2015. Airway IL-1beta and systemic inflammation as predictors of future exacerbation risk in asthma and COPD. Chest. 148(3):618–629.
   PubMed Web of Science ®Google Scholar
• Hudey SN, Ledford DK, Cardet JC. 2020. Mechanisms of non-type 2 asthma. Curr Opin Immunol. 66:123–128.
   PubMed Web of Science ®Google Scholar
• Khorasanizadeh M, Eskian M, Gelfand EW, Rezaei N. 2017. Mitogen-activated protein kinases as therapeutic targets for asthma. Pharmacol Ther. 174:112–126.
   PubMed Web of Science ®Google Scholar
• Kim EK, Choi EJ. 2015. Compromised MAPK signaling in human diseases: an update. Arch Toxicol. 89(6):867–882.
   PubMed Web of Science ®Google Scholar
• Kim RY, Pinkerton JW, Essilfie AT, Robertson AAB, Baines KJ, Brown AC, Mayall JR, Ali MK, Starkey MR, Hansbro NG, et al. 2017. Role for NLRP3 inflammasome-mediated, IL-1beta-dependent responses in severe, steroid-resistant asthma. Am J Respir Crit Care Med. 196(3):283–297.
   PubMed Web of Science ®Google Scholar
• Kim SH, Saba E, Kim BK, Yang WK, Park YC, Shin HJ, Han CK, Lee YC, Rhee MH. 2018. Luteolin attenuates airway inflammation by inducing the transition of CD4+CD25– to CD4+CD25+ regulatory T cells. Eur J Pharmacol. 820:53–64.
   Google Scholar
• Koss CK, Wohnhaas CT, Baker JR, Tilp C, Przibilla M, Lerner C, Frey S, Keck M, Williams CMM, Peter D, et al. 2021. IL36 is a critical upstream amplifier of neutrophilic lung inflammation in mice. Commun Biol. 4(1):172.
   PubMed Web of Science ®Google Scholar
• Li C, Dai J, Dong G, Ma Q, Li Z, Zhang H, Yan F, Zhang J, Wang B, Shi H, et al. 2019. Interleukin-16 aggravates ovalbumin-induced allergic inflammation by enhancing Th2 and Th17 cytokine production in a mouse model. Immunology. 157(3):257–267.
   PubMed Web of Science ®Google Scholar
• Lu Y, Xing QQ, Xu JY, Ding D, Zhao X. 2016. Astragalus polysaccharide modulates ER stress response in an OVA-LPS induced murine model of severe asthma. Int J Biol Macromol. 93(Pt A):995–1006.
   PubMedGoogle Scholar
• Luo Y, Shang P, Li D. 2017. Luteolin: a flavonoid that has multiple cardio-protective effects and its molecular mechanisms. Front Pharmacol. 8:692.
   PubMed Web of Science ®Google Scholar
• Mims JW. 2015. Asthma: definitions and pathophysiology. Int Forum Allergy Rhinol. 5(Suppl. 1):S2–S6.
   PubMed Web of Science ®Google Scholar
• Neurath MF. 2020. IL-36 in chronic inflammation and cancer. Cytokine Growth Factor Rev. 55:70–79.
   PubMed Web of Science ®Google Scholar
• Peebles RS Jr. 2017. Is IL-1beta inhibition the next therapeutic target in asthma? J Allergy Clin Immunol. 139(6):1788–1789.
   PubMed Web of Science ®Google Scholar
• Qin X, Liu M, Zhang S, Wang C, Zhang T. 2019. The role of IL-36γ and its regulation in eosinophilic inflammation in allergic rhinitis. Cytokine. 117:84–90.
   PubMed Web of Science ®Google Scholar
• Ramadas RA, Ewart SL, Medoff BD, LeVine AM. 2011. Interleukin-1 family member 9 stimulates chemokine production and neutrophil influx in mouse lungs. Am J Respir Cell Mol Biol. 44(2):134–145.
   PubMed Web of Science ®Google Scholar
• Samitas K, Zervas E, Gaga M. 2017. T2-low asthma: current approach to diagnosis and therapy. Curr Opin Pulm Med. 23(1):48–55.
   PubMed Web of Science ®Google Scholar
• Shen ML, Wang CH, Lin CH, Zhou N, Kao ST, Wu DC. 2016. Luteolin attenuates airway mucus overproduction via inhibition of the GABAergic system. Sci Rep. 6:32756.
   PubMed Web of Science ®Google Scholar
• Simpson JL, Phipps S, Baines KJ, Oreo KM, Gunawardhana L, Gibson PG. 2014. Elevated expression of the NLRP3 inflammasome in neutrophilic asthma. Eur Respir J. 43(4):1067–1076.
   PubMed Web of Science ®Google Scholar
• Simpson JL, Scott R, Boyle MJ, Gibson PG. 2006. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 11(1):54–61.
   PubMed Web of Science ®Google Scholar
• Svenningsen S, Nair P. 2017. Asthma endotypes and an overview of targeted therapy for asthma. Front Med. 4:158.
   PubMed Web of Science ®Google Scholar
• Towne JE, Garka KE, Renshaw BR, Virca GD, Sims JE. 2004. Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J Biol Chem. 279(14):13677–13688.
   PubMed Web of Science ®Google Scholar
• Wang S, Wuniqiemu T, Tang W, Teng F, Bian Q, Yi L, Qin J, Zhu X, Wei Y, Dong J. 2021. Luteolin inhibits autophagy in allergic asthma by activating PI3K/Akt/mTOR signaling and inhibiting Beclin-1-PI3KC3 complex. Int Immunopharmacol. 94:107460.
   PubMed Web of Science ®Google Scholar
• Wang W, Yu X, Wu C, Jin H. 2017. IL-36gamma inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis. Int J Med Sci. 14(10):1002–1007.
   PubMed Web of Science ®Google Scholar
• Xie K, Chai YS, Lin SH, Xu F, Wang CJ. 2021. Luteolin regulates the differentiation of regulatory T cells and activates IL-10-dependent macrophage polarization against acute lung injury. J Immunol Res. 2021:8883962.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yin Y, Lin X, Yan X, Xia Y, Zhang L, Cao J. 2017. IL-36 induces cytokine IL-6 and chemokine CXCL8 expression in human lung tissue cells: implications for pulmonary inflammatory responses. Cytokine. 99:114–123.
   PubMed Web of Science ®Google Scholar